Millipore Sigma Vibrant Logo

AGX804 2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-4)

This E. coli recombinant protein , Cat. No. AGX804 is tested for use in Lateral Flow Assay.

NewAGX804
1 mg  
Retrieving price...
Price could not be retrieved
Minimum Quantity is a multiple of
Maximum Quantity is
Upon Order Completion More Information
You Saved ()
 
—
Request Pricing
—
Limited AvailabilityLimited Availability
Stocked 
Discontinued
Limited Quantities Available
Available
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

       

      Contact Customer Service

      Overview

      Replacement Information
      Description
      Catalogue NumberAGX804
      Description2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-4)
      Alternate Names
      • SARS-CoV
      • SARS-CoV-2
      Background InformationCoronavirus disease 2019 (COVID-19) is an infectious disease caused by the virus strain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. A SARS-CoV-2 nucleocapsid antigen can be used to support the detection of SARS-CoV-2 (COVID-19, 2019-nCoV).
      References
      Product Information
      FormatPurified
      PresentationPurified protein in 10 mM Phosphate buffer, 150 mM NaCl with no preservatives, pH 7.4.
      Quality LevelMQ100
      Applications
      ApplicationThis E. coli recombinant protein , Cat. No. AGX804 is tested for use in Lateral Flow Assay.
      Key Applications
      • Immunodiffusion
      Application NotesOther recommended antigen products for lateral flow application are AGX806 or AGX808.
      Biological Information
      CloneN/A
      ConcentrationPlease refer to guidance on suggested starting dilutions and/or titers per application and sample type.
      SpecificitySARS-CoV-2
      Purification MethodColumn Purification
      UniProt Number
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsStable for 1 year at -20°C from date of receipt. Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles.
      Packaging Information
      Material Size1 mg
      Transport Information
      Supplemental Information
      Specifications

      Documentation

      2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-4) SDS

      Title

      Safety Data Sheet (SDS) 

      2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-4) Certificates of Analysis

      TitleLot Number
      2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-4) - 3542459 3542459
      2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-4) - 3560625 3560625
      2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-4) - 3593155 3593155
      2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-4) - 3604246 3604246
      2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-4) - 3671314 3671314
      2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-4) - 3701843 3701843
      2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-4) - 3702319 3702319
      2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-4) - Q3471673 Q3471673